Search clinical trials for: combination of everolimus, letrozole and leuprolide

Total 5894 results

Memorial Sloan Kettering Cancer Center
Johns Hopkins University; Novartis Pharmaceuticals; University of California,... and other collaborators

Completed

Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

Fibrolamellar Carcinoma | Fibrolamellar Liver Cancer

United States
Asan Medical Center

Completed

Study of GnRH-A [Leuprorelin(Lorelin Depot] Plus Leterozole +/- Everolimus for Premenopausal Women With Metastatic Breast Cancer (LEO)

Metastatic Breast Cancer

Korea, Republic of
Sinai Hospital of Baltimore

Unknown

Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

Ovarian Cancer | Endometrial Cancer

United States
SWOG Cancer Research Network
National Cancer Institute (NCI)

Active, not recruiting

S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3)

Breast Cancer

United States, Puerto Rico
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Everolimus, Bicalutamide, and Leuprolide Acetate in Treating Patients Undergoing Radiation Therapy For High-Risk Locally Advanced Prostate Cancer

Prostate Cancer

France
University of Washington
National Cancer Institute (NCI)

Terminated

Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer

Breast Cancer

United States
Seung-Jung Park
Abbott Medical Devices; CardioVascular Research Foundation, Korea

Terminated

Bypass Surgery Versus Everolimus-Eluting Stent Implantation for Multivessel Coronary Artery Disease (BEST) (BEST)

Coronary Artery Disease

Thailand, Korea, Republic of, China, Malaysia
Novartis Pharmaceuticals

Completed

Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

Breast Neoplasm

United States, Germany, Spain, United Kingdom, France, Austria, Russian Federation, Italy, Canada, Belgium
University of Maryland, Baltimore
GlaxoSmithKline; Novartis Pharmaceuticals

Terminated

Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer

Breast Neoplasms | Neoplasm Metastasis | Endocrine Breast Diseases

United States
Charite University, Berlin, Germany
Novartis Pharmaceuticals; KKS Netzwerk

Unknown

Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

Breast Cancer

Germany
Novartis Pharmaceuticals

Completed

A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor (OSAT)

Metastatic Renal Cell Carcinoma (mRCC)

Norway
Dana-Farber Cancer Institute
Novartis; Beth Israel Deaconess Medical Center

Completed

Extended Endocrine Therapy for Premenopausal Women With Breast Cancer

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Non-Hodgkin's Lymphoma

Japan
University of Cologne

Completed

SORAVE - Sorafenib and Everolimus in Solid Tumors (SORAVE)

Non-Small Cell Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Germany
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

Trametinib Combined With Everolimus and Lenvatinib for Recurrent/Refractory Advanced Solid Tumors

Hepatocellular Carcinoma | Solid Tumor, Adult

China
Foresee Pharmaceuticals Co., Ltd.
QPS Holdings LLC; Changchun GeneScience Pharmaceutical Co., Ltd.

Recruiting

Efficacy, Safety, and Pharmacokinetics of Leuprolide Mesylate in Subjects With Central Precocious Puberty

Puberty; Precocious, Central

United States, China, Taiwan, Puerto Rico
Novartis Pharmaceuticals

Completed

3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial (LUNA)

Neuroendocrine Carcinoma of the Lung and Thymus

Italy, United Kingdom, Netherlands, Spain, Germany, France, Greece, Denmark, Sweden
University of Michigan Rogel Cancer Center
Novartis Pharmaceuticals

Terminated

Study of Everolimus Added to Combined Hormonal and Radiation Therapy for High Risk Prostate Cancer

Prostate Cancer

United States
Pfizer

Terminated

Pre-Operative Study of PF-4691502 With Letrozole Compared To Letrozole Alone In Patients With Early Breast Cancer

Early Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)

Spain, Sweden, Italy, Belgium
Southern Europe New Drug Organization
Novartis; Schering-Plough

Unknown

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Italy, Switzerland
Arvinas Estrogen Receptor, Inc.
Pfizer

Active, not recruiting

ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer (TACTIVE-E)

Breast Cancer

United States, Spain
Southern Europe New Drug Organization
Bayer; Novartis

Suspended

Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets

Advanced Solid Tumors

Italy
Kyowa Kirin Co., Ltd.
Kyowa Hakko Kirin Pharma, Inc.

Terminated

Safety, Tolerability, and Efficacy Study in Subjects With Advanced or Metastatic Breast Cancer

Breast Cancer

United States
Novartis Pharmaceuticals

Completed

Treatment of Canadian Men and Pre/Peri/Post-menopausal Women With ER+ Advanced Breast Cancer in the Real-World Setting With Hormone Therapy ± Targeted Therapy (Treat ER+ight)

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer

Canada
M.D. Anderson Cancer Center
Novartis

Active, not recruiting

Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

Endometrial Cancer

United States
Abbott

Completed

A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty

Puberty, Precocious

United States, Puerto Rico
University of Utah
University of Chicago; University of Michigan

Completed

Follicle-Stimulating Hormone (FSH) and the Onset of Puberty

Precocious Puberty | Delayed Puberty

United States
Camurus AB

Completed

Phase II Study of Subcutaneous Injection Depot of Leuprolide Acetate in Patient With Prostate Cancer

Prostate Cancer

Finland, Hungary
Gynaecologisch Oncologisch Centrum Zuid
Radboud University Medical Center; Maastricht University Medical Center; Erasmus... and other collaborators

Recruiting

Signal TrAnsduction Pathway Activity Analysis in OVarian cancER (STAPOVER)

Recurrent Ovarian Cancer | Therapy-Associated Cancer | Signal Transduction Pathway Deregulation

Netherlands
Enteris BioPharma Inc.
Syneos Health

Completed

A Study of Pharmacokinetic/Pharmacodynamic Profile of Orally Administered Leuprolide in Healthy Female Volunteers

Endometriosis

Canada
The Netherlands Cancer Institute

Active, not recruiting

Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

Neuroendocrine Carcinomas

Netherlands
Novartis Pharmaceuticals

Terminated

Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC (TRACER)

Hepatocellular Carcinoma

Hong Kong, Taiwan, Thailand
Helsinki University Central Hospital
Foundation for Paediatric Research, Finland

Completed

Constitutional Delay of Growth and Puberty: Towards Evidence-based Treatment (CDGP)

Constitutional Delay of Growth and Puberty

Finland
Enteris BioPharma Inc.
Syneos Health; Parexel

Recruiting

Study to Evaluate the Pharmacodynamics and Efficacy of Leuprolide Tablets (Ovarest®) in Women With Endometriosis

Endometriosis

United States
University of Alabama at Birmingham
Genentech, Inc.

Completed

Open Label Trial for Post-Menopausal Women With Newly Diagnosed Operable Breast Cancer

Breast Cancer

United States
German Breast Group
Novartis

Terminated

Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane (Evelyn)

Metastatic Breast Cancer

Germany
Novartis Pharmaceuticals

Completed

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) (EXIST-2)

Lymphangioleiomyomatosis (LAM) | Tuberous Sclerosis Complex (TSC)

United States, United Kingdom, Germany, Italy, Russian Federation, Netherlands, Japan, Canada, Poland, France, Spain
University of Luebeck

Terminated

Bioresorbable Vascular Scaffolds Versus Stents in Patients With Chronic Total Occlusion (SCORE-CTO)

Coronary Artery Disease

Germany
Foresee Pharmaceuticals Co., Ltd.

Completed

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinoma

Prostatic Neoplasms

Czechia, United States, Poland, Austria, Germany, Lithuania, Slovakia, Taiwan
Ottawa Hospital Research Institute
Canadian Institutes of Health Research (CIHR); University of Ottawa; Queen's...

Completed

PROtecting Ovaries and Fertility During Chemotherapy - The PROOF Trial (PROOF)

Cancer | Fertility Preservation

Canada
GP-Pharm

Terminated

Efficacy and Safety Study of a New Leuprolide Acetate 17 mg Depot to Treat Prostate Cancer Patients

Prostate Cancer

United States
Voyager Pharmaceutical Corporation

Completed

ALADDIN Study: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation

Alzheimer Disease

United States
Foresee Pharmaceuticals Co., Ltd.

Completed

Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancer

Prostatic Neoplasms

Korea, Republic of, United States, Lithuania, Slovakia, Czechia
San Bernardino Urological Associates Medical Group...

Completed

A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg In Patients With Advanced Prostate Cancer

Cancer of Prostate

United States
Queensland Fertility Group

Unknown

GnRH Agonist and Progesterone Versus Progesterone Only for Luteal Phase Support in Antagonist Cycles (GALA)

Infertility

Australia
GP-Pharm

Completed

Leuprolide Acetate 3.75 mg Depot to Treat Prostate Cancer

Prostate Cancer

United States, Austria, Czech Republic, Germany, Hungary, Italy, Slovakia, Spain, United Kingdom
Sinai Hospital of Baltimore

Unknown

Etiology of the Platelet-Cancer Metastatic Pathway - A Study of Inflammatory Markers, Platelet Characteristics and Metastatic Surrogates in Cancer Patients and Controls

Neoplasm

United States
International Cancer Research Group, United Arab...
King Saud University Medical City, Riyadh, Saudi Arabia; Max-Planck-Institut... and other collaborators

Recruiting

Prediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies. (ICRG0201)

Hormonal Receptors Positive, HER2 Negative, Advanced Breast Cancer

Algeria, Jordan, Saudi Arabia
Leiden University Medical Center

Unknown

Everolimus in Treating Patients With Progressive or Recurrent, Unresectable, or Metastatic Thyroid Cancer

Head and Neck Cancer

Netherlands
Novartis Pharmaceuticals

Terminated

Everolimus Post Pazopanib Treatment in Metastatic or Advanced Renal Cell Carcinoma (CATChEz)

Carcinoma, Renal Cell

Australia, Korea, Republic of

Search clinical trials for: combination of everolimus, letrozole and leuprolide

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations